Skip to main content
Premium Trial:

Request an Annual Quote

NuGen Technologies Raises $10.8M in Funding Round

SAN FRANCISCO, Dec. 3 – NuGen Technologies, a privately-held San Carlos, Calif., genetic analysis company, raised $10.8 million in Series B financing, the company announced Monday.

The investor group was led by Pequot Ventures, an investment arm of Pequot Capital Management, based in Westport, Conn. Additional investors included SoftBank LifeScience Ventures, Radius Venture Partners, MedCapital, Band of Angels Fund, and Tenex Medical Investors.

In November 2000, NuGen raised $2 million in Series A financing, led by Tenex Medical Investors, based in Burlingame, Calif.  

NuGen, founded February 2000, has developed a nucleic acid amplification system utilizing its single primer isothermal amplification (SPIA) technology, according to the company.

“SPIA has broad applications spanning industries from life science research, to food safety, to environmental testing,” Jan D'Alvise, CEO of NuGen, said in a statement. “We will form strategic alliances to serve our principal market interests - life science research and diagnostics - and license to deliver SPIA to markets beyond this core focus. 

The Scan

Myotonic Dystrophy Repeat Detected in Family Genome Sequencing Analysis

While sequencing individuals from a multi-generation family, researchers identified a myotonic dystrophy type 2-related short tandem repeat in the European Journal of Human Genetics.

TB Resistance Insights Gleaned From Genome Sequence, Antimicrobial Response Assays

Researchers in PLOS Biology explore M. tuberculosis resistance with a combination of sequencing and assays looking at the minimum inhibitory concentrations of 13 drugs.

Mendelian Disease Genes Prioritized Using Tissue-Specific Expression Clues

Mendelian gene candidates could be flagged for further functional analyses based on tissue-specific transcriptome and proteome profiles, a new Journal of Human Genetics paper says.

Single-Cell Sequencing Points to Embryo Mosaicism

Mosaicism may affect preimplantation genetic tests for aneuploidy, a single-cell sequencing-based analysis of almost three dozen embryos in PLOS Genetics finds.